BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38553383)

  • 1. Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort.
    Nihtilä J; Salmenniemi U; Itälä-Remes M; Crossland RE; Gallardo D; Bogunia-Kubik K; Łacina P; Bieniaszewska M; Giebel S; Hyvärinen K; Kekäläinen E; Ritari J; Partanen J
    Hum Immunol; 2024 Mar; ():110791. PubMed ID: 38553383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation.
    Tsamadou C; Gowdavally S; Platzbecker U; Sala E; Valerius T; Wagner-Drouet E; Wulf G; Kröger N; Murawski N; Einsele H; Schaefer-Eckart K; Freitag S; Casper J; Kaufmann M; Dürholt M; Hertenstein B; Klein S; Ringhoffer M; Frank S; Neuchel C; Rode I; Schrezenmeier H; Mytilineos J; Fuerst D
    Bone Marrow Transplant; 2022 Oct; 57(10):1539-1547. PubMed ID: 35804057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human thymopoiesis is influenced by a common genetic variant within the
    Clave E; Araujo IL; Alanio C; Patin E; Bergstedt J; Urrutia A; Lopez-Lastra S; Li Y; Charbit B; MacPherson CR; Hasan M; Melo-Lima BL; Douay C; Saut N; Germain M; Trégouët DA; Morange PE; Fontes M; Duffy D; Di Santo JP; Quintana-Murci L; Albert ML; Toubert A;
    Sci Transl Med; 2018 Sep; 10(457):. PubMed ID: 30185651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable outcome after haploidentical and HLA-matched allogeneic stem cell transplantation for high-risk acute myeloid leukemia following sequential conditioning-a matched pair analysis.
    Doppelhammer M; Fraccaroli A; Prevalsek D; Bücklein V; Häbe S; Schulz C; Hubmann M; Hausmann A; Claus R; Rank A; Schmid C; Tischer J
    Ann Hematol; 2019 Mar; 98(3):753-762. PubMed ID: 30617644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.
    Piemontese S; Ciceri F; Labopin M; Arcese W; Kyrcz-Krzemien S; Santarone S; Huang H; Beelen D; Gorin NC; Craddock C; Gulbas Z; Bacigalupo A; Mohty M; Nagler A;
    J Hematol Oncol; 2017 Jan; 10(1):24. PubMed ID: 28103944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of Patients with Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: An Experience in Developing Country.
    Mehdizadeh M; Bolourian V; Zamani G; Tavakoli-Ardakanii M; Zamani S; Tabarraee M; Hajifathali A
    Int J Hematol Oncol Stem Cell Res; 2022 Jan; 16(1):55-65. PubMed ID: 35975120
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia.
    Candoni A; De Marchi F; Zanini F; Zannier ME; Simeone E; Toffoletti E; Chiarvesio A; Cerno M; Filì C; Patriarca F; Fanin R
    Exp Hematol; 2017 May; 49():25-33. PubMed ID: 28159598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study.
    Vaht K; Göransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Andersson PO; Brune M
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1970-1974. PubMed ID: 31173901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation.
    Granell M; Urbano-Ispizua A; Pons A; Aróstegui JI; Gel B; Navarro A; Jansa S; Artells R; Gaya A; Talarn C; Fernández-Avilés F; Martínez C; Rovira M; Carreras E; Rozman C; Juan M; Yagüe J; Montserrat E; Monzó M
    Blood; 2008 Nov; 112(10):4337-42. PubMed ID: 18772453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in the genes encoding human interleukin-7 receptor-alpha: prognostic significance in allogeneic stem cell transplantation.
    Shamim Z; Ryder LP; Heilmann C; Madsen H; Lauersen H; Andersen PK; Svejgaard A; Jacobsen N; Müller K
    Bone Marrow Transplant; 2006 Mar; 37(5):485-91. PubMed ID: 16435014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Shimoni A; Labopin M; Savani B; Byrne M; Volin L; Finke J; Niederwieser D; Ehninger G; Blaise D; Beelen D; Tabrizi R; Sengeloev H; Ganser A; Cornelissen JJ; Mohty M; Nagler A
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2251-2260. PubMed ID: 31271887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis.
    Ma L; Han X; Jiang S; Meng Q; Zhang L; Bao H
    Hematology; 2020 Dec; 25(1):356-365. PubMed ID: 33054609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Candoni A; De Marchi F; Zannier ME; Lazzarotto D; Filì C; Dubbini MV; Rabassi N; Toffoletti E; Lau BW; Fanin R
    Leuk Res; 2017 Dec; 63():22-27. PubMed ID: 29096332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia.
    Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
    Ann Hematol; 2019 May; 98(5):1267-1277. PubMed ID: 30747249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center.
    Loirat M; Chevallier P; Leux C; Moreau A; Bossard C; Guillaume T; Gastinne T; Delaunay J; Blin N; Mahé B; Dubruille V; Augeul-Meunier K; Peterlin P; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Mohty M; Moreau P; Le Gouill S
    Ann Oncol; 2015 Feb; 26(2):386-92. PubMed ID: 25392158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
    Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma.
    Ulaner GA; Goldman DA; Sauter CS; Migliacci J; Lilienstein J; Gönen M; Schöder H; Moskowitz CH; Zelenetz AD
    Radiology; 2015 Nov; 277(2):518-26. PubMed ID: 26035588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial.
    Röllig C; Bornhäuser M; Kramer M; Thiede C; Ho AD; Krämer A; Schäfer-Eckart K; Wandt H; Hänel M; Einsele H; Aulitzky WE; Schmitz N; Berdel WE; Stelljes M; Müller-Tidow C; Krug U; Platzbecker U; Wermke M; Baldus CD; Krause SW; Stölzel F; von Bonin M; Schaich M; Serve H; Schetelig J; Ehninger G
    J Clin Oncol; 2015 Feb; 33(5):403-10. PubMed ID: 25547501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
    Ferrá C; Sanz J; de la Cámara R; Sanz G; Bermúdez A; Valcárcel D; Rovira M; Serrano D; Caballero D; Espigado I; Morgades M; Heras I; Solano C; Duarte R; Barrenetxea C; García-Noblejas A; Díez-Martin JL; Iriondo A; Carreras E; Sierra J; Sanz MA; Ribera JM;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):957-66. PubMed ID: 20144909
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.